Please login to the form below

Not currently logged in
Email:
Password:

Hall & Partners boosts senior health team

Appoints Jeanette Hodgson and promotes Marie Bennett

Hall & Partners H&P Jeanette HodgsonResearch specialist Hall & Partners has appointed two new partners to its health team.

Qualitative health researcher Jeanette Hodgson (pictured) joins Hall & Partners' London-based health team after several years of running her own consulting practice, while Marie Bennett has been promoted.

Hodgson has a wealth of experience in the pharmaceutical sector and has pioneered approaches that uncover the human motivations which drive positive health behaviours.  

Bennett most recently served as a research director for Hall & Partners, prior to which she held similar roles with Adelphi Research and AstraZeneca Pharmaceuticals.

“We are delighted to have persuaded Jeanette to join us. She is one of the most respected leaders in our industry, a great thinker and strategist. The fact that Jeanette chose H&P speaks volumes about our reputation as a leading agency,” said managing partner, health, Lee Gazey.

Lee commented on Marie's promotion: “Since joining Hall & Partners three years ago, Marie has made significant contributions to the company's health business. She is also a great leader. We are very excited for her to take on this new role.”

15th April 2014

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics